z-logo
open-access-imgOpen Access
MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome
Author(s) -
Rachel Bayley,
Daniel Blakemore,
Paloma García
Publication year - 2018
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.26477
Subject(s) - biomarker , medicine , myelodysplastic syndromes , oncology , cancer research , gene expression , bioinformatics , biology , genetics , gene , bone marrow

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here